Multifactorial Intervention on Diabetes (MIDiab Study)

  • End date
    Dec 31, 2022
  • participants needed
  • sponsor
    Shandong Provincial Hospital
Updated on 13 February 2022
behavior modification


The prevalence of diabetes mellitus has been increasing in recent decades in China, and vascular complication is the major burden in patients with type 2 diabetes. Previous studies demonstrated that only glycemic control was not effective enough to prevent or improve diabetic vascular complications, but guidelines from the Chinese Diabetes Society and other national guidelines recommend an integrated multifactorial treatment approach. In this study, we aim to evaluate the effect on diabetic vascular complications of a multifactorial intervention comprising behavior modification, polypharmacological therapy and periodical monitoring in patients with type 2 diabetes.

Condition Diabetes Mellitus, Type 2
Treatment lifestyle therapy, Pharmacotherapy, Monitoring and management, General treatment
Clinical Study IdentifierNCT03430284
SponsorShandong Provincial Hospital
Last Modified on13 February 2022


Yes No Not Sure

Inclusion Criteria

35-75 years old
diagnosed as type 2 diabetes according to the criteria of the World Health Organization in 1999

Exclusion Criteria

type 1 diabetesspecific types of diabetesgestational diabetes or pregestational diabetes
acute cardiovascular or cerebrovascular accidents within past 3 months
severe hepatic or renal dysfunction
malignant tumor
allergic history or contraindication for any drugs in trials
taking part in other clinical trials
obviously poor compliance
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note